CS logo
small CS logo
Viking Clinical Research

Temecula, California, United States
Research institute in Temecula, California
29645 Rancho California Rd #133, Temecula, CA 92591

About Viking Clinical Research


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Naurex, Inc, an affiliate of Allergan plc
6
Otsuka Pharmaceutical Development & Commercialization, Inc.
4
Boehringer Ingelheim
2
Cephalon
2
Janssen Research & Development, LLC
2
Novartis
2
Novartis Pharmaceuticals
2
Pfizer
2
ACADIA Pharmaceuticals Inc.
1
Assurex Health Inc.
1
Bial - Portela C S.A.
1
Total Rows: 15

Clinical Trials at Viking Clinical Research


During the past decade, Viking Clinical Research conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 16 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 8 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22442233112200223300002233661111Started TrialsCompleted Trails2015201620172018201920202021202202468
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
2006-07-01
2007-03-01
Completed
Eslicarbazepine Acetate Monotherapy Long Term Study
2009-08-01
2017-04-15
Completed
274
Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44
2009-07-01
2012-06-01
Completed
716
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures
2008-12-02
2012-01-12
Completed
653
Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
2010-03-01
2012-11-01
Completed
492
A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
2010-01-01
2012-03-01
Completed
433
Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
2010-05-01
2011-06-01
Completed
589
Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
2010-06-01
2011-10-01
Terminated
837

Rows per page:

1–29 of 29

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Viking Clinical Research" #1 sponsor was "Naurex, Inc, an affiliate of Allergan plc" with 6 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Cephalon" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Viking Clinical Research" #1 collaborator was "Amsterdam UMC, location VUmc" with 1 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "Sunovion" with 1 trials as a collaborator, "University of Michigan" with 1 trials as a collaborator and "Worldwide Clinical Trials" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNaurex, Inc, an affiliateof Allergan plc: 6Naurex, Inc, an affiliateof Allergan plc: 6Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:4Otsuka PharmaceuticalDevelopment &Commercialization, Inc.:4Boehringer Ingelheim: 2Boehringer Ingelheim: 2Cephalon: 2Cephalon: 2Janssen Research &Development, LLC: 2Janssen Research &Development, LLC: 2Novartis: 2Novartis: 2Novartis Pharmaceuticals: 2Novartis Pharmaceuticals: 2Pfizer: 2Pfizer: 2ACADIA Pharmaceuticals Inc.: 1ACADIA Pharmaceuticals Inc.: 1Assurex Health Inc.: 1Assurex Health Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsAmsterdam UMC,location VUmc: 1Amsterdam UMC,location VUmc: 1Otsuka PharmaceuticalCo., Ltd.: 1Otsuka PharmaceuticalCo., Ltd.: 1Sunovion: 1Sunovion: 1University of Michigan: 1University of Michigan: 1Worldwide Clinical Trials: 1Worldwide Clinical Trials: 1

Clinical Trials Conditions at Viking Clinical Research


According to Clinical.Site data, the most researched conditions in "Viking Clinical Research" are "Depressive Disorder, Major" (9 trials), "Depression" (3 trials), "Major Depressive Disorder" (3 trials), "Borderline Personality Disorder" (2 trials) and "Major Depressive Disorder (MDD)" (2 trials). Many other conditions were trialed in "Viking Clinical Research" in a lesser frequency.

Clinical Trials Intervention Types at Viking Clinical Research


Most popular intervention types in "Viking Clinical Research" are "Drug" (28 trials), "Other" (4 trials) and "Genetic" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (15 trials), "Rapastinel" (6 trials), "placebo" (3 trials), "Armodafinil" (2 trials) and "Aticaprant" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Viking Clinical Research


The vast majority of trials in "Viking Clinical Research" are 29 trials for "All" genders.

Clinical Trials Status at Viking Clinical Research


Currently, there are NaN active trials in "Viking Clinical Research". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Viking Clinical Research, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Viking Clinical Research, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 20Phase 3: 20Phase 2: 5Phase 2: 5Phase 4: 3Phase 4: 3Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 21Completed: 21Recruiting: 4Recruiting: 4Terminated: 4Terminated: 4